Brian T. Powl, Chief Commercial Officer of Kura Oncology ($KURA), sold shares on the open market four times in the last 365 days for a total of $233,100. His most recent sale occurred on January 27, 2026. These sales rank in the 8,100th place among 11,678 insiders, below the average sale amount of $8.6 million across 6.4 transactions. Powl made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 27, 2026 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 1572 | $8.46 | 183,275.0000 | 87,645,000 | 0.85% | 0.00% |
| Jan. 27, 2026 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 4842 | $8.46 | 184,847.0000 | 87,645,000 | 2.55% | 0.01% |
| Jan. 2, 2026 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Common Stock | 50000 | $0.00 | 189,689.0000 | 87,645,000 | 35.79% | 0.06% |
| Jan. 2, 2026 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Option to purchase common stock | 100000 | $0.00 | 100,000.0000 | 87,645,000 | 9999.99% | 0.11% |
| Nov. 14, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 8887 | $11.18 | 139,689.0000 | 87,645,000 | 5.98% | 0.01% |
| Nov. 13, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Common Stock | 48900 | $0.00 | 148,576.0000 | 87,645,000 | 49.06% | 0.06% |
| Sept. 29, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 8891 | $8.94 | 99,676.0000 | 86,161,000 | 8.19% | 0.01% |
| Sept. 27, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Common Stock | 48900 | $0.00 | 108,567.0000 | 86,161,000 | 81.95% | 0.06% |
| Jan. 28, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 1583 | $7.87 | 59,667.0000 | 86,161,000 | 2.58% | 0.00% |
| Jan. 2, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Common Stock | 46250 | $0.00 | 61,250.0000 | 86,161,000 | 308.33% | 0.05% |
| Jan. 2, 2025 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Option to purchase common stock | 92500 | $0.00 | 92,500.0000 | 86,161,000 | 9999.99% | 0.11% |
| Jan. 2, 2024 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Option to purchase common stock | 30000 | $0.00 | 30,000.0000 | 73,229,000 | 9999.99% | 0.04% |
| Jan. 2, 2024 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Common Stock | 15000 | $0.00 | 15,000.0000 | 73,229,000 | 9999.99% | 0.02% |
| Aug. 14, 2023 | Kura Oncology, Inc. | $KURA | Powl Brian T. | Chief Commercial Officer | A | Option to purchase common stock | 200000 | $0.00 | 200,000.0000 | 66,990,000 | 9999.99% | 0.30% |
| July 5, 2023 | FATE THERAPEUTICS INC | $FATE | Powl Brian T. | Chief Commercial Officer | S | Common Stock | 3854 | $4.87 | 41,146.0000 | 0 | 8.56% | 0.00% |
| Feb. 6, 2023 | FATE THERAPEUTICS INC | $FATE | Powl Brian T. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 0 | 9999.99% | 0.00% |